Home Clinical Topics FDA approves drug for ALS

FDA approves drug for ALS

On May 5, the U.S. Food and Drug Administration (FDA) approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS). Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here